Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

26.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.1K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

755
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
755
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

889
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
889
Tumor Immunotherapy01:27

Tumor Immunotherapy

741
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
741
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.9K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
Glaucoma: Overview01:25

Glaucoma: Overview

987
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
987

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transferrin is a drug candidate for the treatment of dry age-related macular degeneration (AMD).

Cell death & disease·2025
Same author

Neuroprotective Effects of Transferrin in Experimental Glaucoma Models.

International journal of molecular sciences·2022
Same author

[Anti-TNF-α in the treatment of non-infectious uveitis].

Medecine sciences : M/S·2020
Same author

Transferrin Non-Viral Gene Therapy for Treatment of Retinal Degeneration.

Pharmaceutics·2020
Same author

Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives.

Drug discovery today·2019
Same author

Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome.

Molecular therapy. Methods & clinical development·2019

Related Experiment Video

Updated: Oct 18, 2025

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

21.6K

Gene Therapy for Uveitis

Ronald R Buggage, Thierry Bordet

    International Ophthalmology Clinics
    |September 29, 2021
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
    07:40

    Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

    Published on: January 12, 2022

    5.3K
    Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
    06:16

    Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models

    Published on: March 16, 2022

    3.2K

    Related Experiment Videos

    Last Updated: Oct 18, 2025

    Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
    06:48

    Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

    Published on: August 7, 2015

    21.6K
    Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
    07:40

    Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

    Published on: January 12, 2022

    5.3K
    Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
    06:16

    Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models

    Published on: March 16, 2022

    3.2K